Pharmacoepidemiology may be defined as the study of the utilization and effects of drugs in large numbers of people. To accomplish this study, pharmacoepidemiology borrows from both pharmacology and epidemiology. Thus, pharmacoepidemiology can be called a bridge science spanning both pharmacology and epidemiology. (ISPE Website)
The IOM defines CER as the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat and monitor a clinical condition, or to improve the delivery of care. The purpose of CER is to assist consumers, clinicians, purchasers, and policy makers to make informed decisions that will improve health care at both the individual and population levels.
Friedman's "fundamental theorem" of biomedical informatics states that the combination of human intelligence and information resources is more powerful than human intelligence alone. Realizing the potential benefits of this combination requires careful attention to the design and evaluation of user interfaces that will help users maximize the utility of information resources. Harry Hochheiser, PhD uses techniques of contextual inquiry and prototyping to develop bioinformatics interfaces for the FaceBase project.
The purpose of the project was to maintain and expand the Commonwealth of Pennsylvania’s public health surveillance system.
This intramurally awarded K grant provided me with salary support during my transition to becoming an independently-funded, translational scientist. It supported tuition for training in comparative effectiveness research and pharmacoepidemiology. As part of this grant, I developed my research program in informatics to improve medication safety.